Background While inferior to oxytocin injection in both efficacy and safety, orally
administered misoprostol has been included in the World Health Organization Model List of …

Postpartum haemorrhage (PPH) causes preventable maternal deaths, mainly in low-income
countries. Misoprostol has powerful uterotonic effects and, because it is well absorbed orally …

Background: Postpartum haemorrhage (PPH) is a leading cause of maternal mortality
especially in the developing world. Misoprostol, a highly effective drug is highly effective in …

Background Postpartum heammorrhage (PPH), defined as blood loss greater than or equal
to 500 ml within 24 hours after birth, is the leading cause of maternal deaths globally and in …

Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide.
Studies suggest that the use of misoprostol may be beneficial in clinical settings where …

As a stable, orally active and cheap uterotonic, misoprostol would appear ideally suited to
the prevention of postpartum hemorrhage (PPH) in the developing world. Following …

Misoprostol is an effective and safe uterotonic for the prevention and treatment of postpartum
hemorrhage (PPH). A 600‐μg oral dose of misoprostol has been shown to prevent PPH in …

Background Using misoprostol to prevent postpartum haemorrhage (PPH) in home‐birth
settings remains controversial. Objectives To review the safety and effectiveness of oral …

Objective: To assess misoprostol's ability to prevent postpartum hemorrhage (PPH) where
no alternatives exist. Comparison to oxytocics demonstrates how similarly misoprostol …

Background A myriad of interventions exist to treat postpartum hemorrhage (PPH), ranging
from uterotonics and hemostatics to surgical and aortic compression devices. Nonetheless …